Today: 20 June 2026

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax shares fell 9.49% to 99.20 euros in Paris on Thursday, reversing a 6% gain from the previous day. Volume reached about 246,000 shares amid anticipation of Phase 3 trial results for obefazimod in late Q2 2026. A U.S. Form 144 filing showed Sofinnova Crossover I SLP intends to sell up to 1,000,000 ADS. BTIG raised its price target on Abivax to $150 and maintained a “Buy” rating.
8 January 2026
·
Exxon Mobil stock (XOM) rises as filing flags Q4 upstream hit from weaker crude; Jan 30 next

Exxon Mobil stock (XOM) rises as filing flags Q4 upstream hit from weaker crude; Jan 30 next

Exxon Mobil shares rose 3.3% to $122.42 by early afternoon Thursday after the company warned that lower crude prices could cut fourth-quarter upstream earnings by $0.8 billion to $1.2 billion from the prior quarter. Exxon said stronger refining margins may add $0.3 billion to $0.7 billion. The company reports results Jan. 30. Traders are watching oil price swings and estimate changes.
8 January 2026
···
Teleflex (TFX) stock dives on CEO exit and revenue forecast cut — what investors watch next

Teleflex (TFX) stock dives on CEO exit and revenue forecast cut — what investors watch next

Teleflex shares fell 11.7% to $111.76 Thursday after the company announced CEO Liam Kelly’s exit and cut its 2025 revenue forecast. Stuart Randle was named interim chief executive, with a $140,000 monthly stipend and $1.5 million in stock. Teleflex cited weak demand for balloon pumps and OEM order delays. The company expects to report full results in late February or early March.
8 January 2026
·
Why Applied Optoelectronics (AAOI) stock is down today as tech pulls back

Why Applied Optoelectronics (AAOI) stock is down today as tech pulls back

Applied Optoelectronics (AAOI.O) dropped 14.9% to $32.40 in Thursday afternoon trading, with 6.2 million shares traded and an intraday low of $31.70. The decline followed a broader selloff in tech stocks, leaving the Nasdaq down 0.5% midday. Optical networking peers Ciena, Lumentum, and Coherent also fell sharply. Investors are watching Friday’s U.S. payrolls report and AAOI’s earnings update in late February.
8 January 2026
··
Silver price stock SLV slides as index rebalance selling kicks in ahead of U.S. jobs report

Silver price stock SLV slides as index rebalance selling kicks in ahead of U.S. jobs report

iShares Silver Trust dropped 3.5% to $68.50 in midday New York trading, tracking a broader selloff in silver assets as spot silver fell 2.5% to $76.19 an ounce. Traders cited commodity index rebalancing and a stronger dollar ahead of Friday’s U.S. payrolls report. Silver miners slipped less, down 0.4% to 1%. Sterling weakened for a third day as the dollar firmed.
8 January 2026
······
Dow Jones ETF DIA rises as tech slips and Trump defense headlines jar Wall Street before payrolls

Dow Jones ETF DIA rises as tech slips and Trump defense headlines jar Wall Street before payrolls

The SPDR Dow Jones Industrial Average ETF Trust rose 0.6% to $492.73 Thursday as the Dow climbed 304 points, while the Nasdaq slipped on tech losses. Weekly jobless claims increased to 208,000 and continuing claims reached 1.914 million. Defense stocks rebounded after President Trump proposed a $1.5 trillion military budget for 2027. Investors await Friday’s U.S. nonfarm payrolls report.
8 January 2026
··
Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience shares plunged 18.5% to $43.10 Thursday after hitting $69.97 earlier in the session, triggering five volatility halts. Over 3 million shares traded by early afternoon, far above average. The company has warned of “substantial doubt” about its ability to continue operating and reported net losses of $3.58 million for the year ended June 2025. No company statement explained the sharp swings.
8 January 2026
··
Why Westlake stock is jumping today after its ACI deal filing

Why Westlake stock is jumping today after its ACI deal filing

Westlake Corp shares rose 7.4% to $79.98 Thursday after the company said it completed its acquisition of ACI/Perplastic Group’s global compounding solutions businesses. The deal expands Westlake’s manufacturing into Portugal, Romania, and Tunisia. Financial terms were not disclosed. Other major U.S. chemical stocks also gained.
8 January 2026
·
UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth Group Incorporated stock rises as House summons insurer CEOs; investors eye two January dates

UnitedHealth shares rose 1.3% to $346.11 after U.S. House lawmakers called major health insurer CEOs to testify on coverage affordability January 22. Senators Wyden and Warren accused UnitedHealth of withholding documents in a nursing-home probe, setting a January 28 deadline. TPG is in advanced talks to buy UnitedHealth’s Optum UK unit for up to £1.4 billion, Sky News reported.
8 January 2026
····
IREN stock jumps nearly 8% as AI data-center trade returns; earnings are the next test

IREN stock jumps nearly 8% as AI data-center trade returns; earnings are the next test

IREN shares jumped 7.7% to $46.99 in Thursday afternoon trading, tracking gains in data-center stocks after Applied Digital announced talks with a major cloud customer. IREN operates U.S. and Canadian data centers for bitcoin mining and AI compute, with about 1,896 Nvidia GPUs. Its $9.7 billion, five-year GPU cloud deal with Microsoft includes strict delivery terms. Next results are expected in February, with focus on GPU rollout and funding.
8 January 2026
····
AbbVie stock drops after Revolution deal denial, $1.3 billion charge spooks traders

AbbVie stock drops after Revolution deal denial, $1.3 billion charge spooks traders

AbbVie shares fell 3.7% to $224.84 Thursday after the company denied takeover talks with Revolution Medicines and flagged a $1.3 billion fourth-quarter charge tied to R&D and milestone payments. AbbVie trimmed its 2025 profit forecast, setting adjusted earnings at $9.90 to $9.94 per share. Revolution Medicines dropped 5.5%. Wolfe Research downgraded AbbVie, citing limited upside.
8 January 2026
··
Trump’s New $100 U.S. National Park Fee for Foreign Tourists Kicks In — and 10 States Race Ahead in Crypto

Trump’s New $100 U.S. National Park Fee for Foreign Tourists Kicks In — and 10 States Race Ahead in Crypto

Foreign visitors to 11 major U.S. national parks, including Yosemite and Yellowstone, now pay a $100 per-person surcharge on top of regular entrance fees, the National Park Service said. The Center for Biological Diversity has sued, arguing the fee and new resident/nonresident pass categories violate federal law. The new policy requires staff to check IDs at park gates and changes how tour groups are processed.
8 January 2026
Nebius (NBIS) stock bounces back near $100 as Nvidia Rubin talk keeps AI cloud names jumpy

Nebius (NBIS) stock bounces back near $100 as Nvidia Rubin talk keeps AI cloud names jumpy

Nebius shares rose nearly 4% to $100.03 in midday Nasdaq trading Thursday after the AI cloud company announced plans to offer early access to Nvidia’s Rubin platform starting in the second half of 2026. The stock rebounded after a previous session drop, while Nvidia slipped 2%. Investors are watching a Jan. 29 product webinar and the company’s next earnings update in mid-February.
8 January 2026
····
1 … 952 953 954 955 956 … 2,086

Stock Market Today

  • SSR Mining Rises on TSX with Analyst Predicting 56% Upside Amid Buybacks
    June 19, 2026, 6:53 PM EDT. SSR Mining Inc. (SSRM) surged over 12% this week on the S&P/TSX composite, propelled by robust buyback activity. Analyst Richard Gray of ATB Cormark Capital Markets reiterated a $68 price target, implying a 56% upside from Friday's close at $43.54. The company spent $300 million on share repurchases in Q2 2026 and received approval for an additional $500 million buyback, signaling strong free cash flow expectations. SSR has gained 42% year to date despite recent volatility. The stock remains below its 2026 high of $49.41 and holds a 12-month consensus target of $60.37 from 10 analysts, according to Bloomberg data. SSR's focus on North American operations and growth prospects underpins investor confidence.

Latest articles

JBS shutdowns put pressure on U.S. beef as cattle prices rise

JBS shutdowns put pressure on U.S. beef as cattle prices rise

20 June 2026
JBS USA will close its Souderton, PA, and Memphis, TN, meat plants on August 14, cutting 1,693 jobs as tight cattle supplies drive negative U.S. beef margins; USDA data show beef prices up 14.8% year-over-year and forecast to rise another 12.1% in 2026, signaling ongoing cost pressure for packers and consumers.
TSMC Leads Nvidia in Short Week Chip Gains

TSMC Leads Nvidia in Short Week Chip Gains

20 June 2026
TSMC’s U.S.-listed shares soared 6.9% to $462.12, outpacing Nvidia’s 3.0% gain, as investors favored broad chip manufacturing exposure after an interim U.S.-Iran deal eased inflation fears and Taiwan’s central bank raised its 2026 economic-growth forecast to 9.45% on AI-driven semiconductor demand.
Intel Beats AMD for Week After Trump Comments on Apple Chips

Intel Beats AMD for Week After Trump Comments on Apple Chips

20 June 2026
Intel soared 10.6% to a record $133.99 after President Trump said Apple agreed to work with Intel on U.S. chip design and production, though neither company confirmed terms or details; analysts are split on the deal’s value, with Intel’s gains outpacing AMD’s 4.9% rise as the chip sector hit a record close.
Go toTop